Cognigenics
Cognigenics develops innovative RNA-based gene therapies targeting memory loss, cognitive decline, anxiety associated with mild cognitive impairment and other neurocognitive and neuropsychiatric disorders. Our intranasal delivery platform targets neuronal receptors in the brain involved in CNS disorders including anxiety, and Mild Cognitive Impairment.
7-day free trial · no credit card
Verified contacts
9
available on Kipplo
LinkedIn employees
18
11 to 50 range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 9 verified contacts at Cognigenics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
9 contacts with verified email or phone · masked until revealed.
- TR
Troy Rohn
Director of Preclinical Studies · Science
EmailPhone - DR
Dean Radin
Chairman · General Business & Management
EmailPhone - FM
Fabio MacCiardi
Chief Scientific Officer · Research & Development
EmailPhone - PS
Peter Seidler
Chief Communications Officer (CCO) · General Business & Management
EmailPhone
Showing 4 of 9 verified contacts
Top roles at Cognigenics
7 distinct titles indexed · top 7 shown.
- 1back office executive
- 1chairman
- 1chief communications officer (cco)
- 1chief scientific officer
- 1director of preclinical studies
- 1executive assistant
- 1investor relations officer
Sign up to unlock all 9 contacts at Cognigenics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 9 verified contacts at Cognigenics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.